The NHS has launched a new pilot service that aims could help thousands of patients detect possible signs of throat cancer by using a new iPhone device.
The adapter features a 32mm lens and an app that can turn an iPhone into a portable diagnostic gadget which can detect or rule out existing signs of throat cancer.
With the tool, NHS staff can capture live endoscopy examinations of the throat in high definition (HD) and share the results in real-time with head and neck specialists via a secure data cloud. The specialists can then examine the data and send diagnostic reports directly to patients.
The pilot, which has so far been tested on over 1,800 patients, has shown that no cancers were missed using the device, with patients able to receive their results within 23 hours of the test taking place.
The device is being initially trialled across the West Midlands, with the health service planning to use it in any NHS setting, including diagnostic centres and community settings.
The NHS said it aims to improve services and shorten patients’ waiting time for diagnosis, who will be able to get tested directly at home.
Health minister Karin Smyth emphasised how the new technology is a “shining example” of how innovation and research can tackle waiting lists, improve patient experience, and speed up diagnosis.
“Using the app, patients can access a potentially lifesaving consultation. By catching cancer earlier and treating it faster, we can ensure more people survive this horrible disease,” she said.
Dr Cally Palmer, NHS England national cancer director, said that using technology to support the NHS represents a key part of the organisation’s 10-Year Health Plan. The plan involves shifting the NHS from analogue to digital and equipping the health service with more cutting edge-technologies to catch cancers on time.
“The NHS continues to adopt the latest technologies with the potential to benefit patients, and through pioneering new innovations like this iPhone device which could be used in any setting, we hope we’ll be able to detect many more cancers sooner and in ways that are more convenient and less invasive for patients,” said Palmer.